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Abstract
Castleman’s disease (CD) or angiofollicular lymph node hyperplasia is a rare spectrum of lymphoproliferative
disorders. CD tumors are commonly localized in the mediastinum and are usually asymptomatic. The mainstay of
treatment is surgical resection and has typically been performed using open thoracotomy. Few reports in the
literature describe video assisted thoracoscopic resection of these tumors. The differential diagnosis for mediastinal
masses is extensive, and CD tumors, although uncommon, should be considered. We describe a case report of a
posterior mediastinal Castleman’s tumor adherent to the esophagus, which was resected thoracoscopically and
review the literature.
Introduction
First described in 1954, Castleman’s disease (CD)[1] is a
rare lymphoproliferative disorder involving lymphocyte
proliferation and excessive cytokine production. The
characteristic lymphoid tumors may occur singly or in a
multicentric pattern, the latter being more commonly
associated with signs and symptoms including fever,
weight loss, anemia, anorexia, and low white blood cell
count.
Surgical resection is the mainstay of treatment for uni-
centric mediastinal CD[2] and has been typically per-
formed via standard thoracotomy[3-5]. While video-
assisted thoracoscopic surgical (VATS) resection has
become an effective and reliable option for excising
mediastinal masses[6,7], very few reports describe resec-
tion of mediastinal CD using this approach[8-11].
Because these tumors are highly vascular and often have
dense adhesions to the surrounding tissue, they must be
approached with great care especially in the mediasti-
num given the close proximity to vital structures[4,12].
We report our experience with a rare posterior mediast-
inal CD tumor adherent to the esophagus and review
the literature.
Case report
A 54-year-old Hispanic male presented to the emer-
gency department with abdominal pain. He denied any
history of fever, night sweats, weight loss or fatigue. He
denied any dysphagia but complained of mild anorexia.
Physical examination was essentially normal except mild
tenderness over the spleen. Complete blood count and
comprehensive metabolic panel were within normal lim-
its. A contrast-enhanced computed tomographic scan of
the abdomen and pelvis incidentally detected a posterior
m e d i a s t i n a lm a s sm e a s u r i n g5×3×2c ma sw e l la s
moderate splenomegaly (Figure 1). There was no radi-
ological evidence of invasion of the adjacent vasculature,
heart, diaphragm or bony tissues. A positron emission
tomography (PET) scan was not performed.
Complete surgical resection using VATS was underta-
ken under single-lung anesthesia using a 10-mm and
two 5-mm ports. The mass was visualized and located
between the azygous vein and the esophagus (Figure 2).
The parietal pleura was incised and the 5 × 2.5 × 1.5
cm densely adherent and highly vascularized mass (Fig-
ure 3) was separated from the esophagus using electro-
cautery as well as sharp and blunt dissection. The
thoracic duct located adjacent to the mass was ligated
securely. An esophageal leak test using saline in the
pleural cavity and air insufflated into the esophageal
lumen confirmed the integrity of the esophageal
mucosa. The patient’s postoperative course was entirely
uneventful. A serum analysis for HIV infection was
negative. Pathologic examination of the dark brown,
encapsulated mass confirmed the diagnosis of hyaline-
vascular CD, an unexpected diagnosis. The patient has
been asymptomatic on the subsequent follow-up. His
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whether the patient’s splenomegaly was related to CD.
Discussion
Castleman’s disease (CD), also known as angiofollicular
lymph node hyperplasia, giant lymph node hyperplasia,
lymph node hamartoma, as well as benign lymph node
lymphoma, was first described by Dr. Benjamin Castle-
man in a patient with solitary mediastinal lymph nodes
in 1954[1] and in a group of largely asymptomatic
patients with benign mediastinal lymphadenopathy in
1956[13]. It is now considered part of the uncommon
spectrum of lymphoproliferative disorders which have
several distinct pathological and clinical variants[14].
Previously classified broadly into unicentric and multi-
centric types, recent authors favor defining CD by histo-
pathogenic type into hyaline-vascular CD, plasma cell
CD, human herpes virus-8 (HHV-8) associated CD (also
known as plasmablastic CD) and multicentric CD, not
otherwise specified. The hyaline-vascular CD accounts
for approximately 70% of patients with CD and involve
men and women equally[15].
W h i l et h ee t i o l o g yi su n c e r t a i n ,p a t h o g e n i cf a c t o r s
such as HHV-8 and interleukin-6 (IL-6) have been
Figure 1 CT scan images of the posterior mediastinal mass.
Figure 2 Thoracoscopic view of posterior mediastinal
structures.
Figure 3 Thoracoscopic view of the posterior mediastinal mass
with the edges of the mediastinal pleura divided (arrows).
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CD is multicentric and has a risk of progression to large
B-cell lymphoma. Human immunodeficiency virus
(HIV) positive patients with CD are almost always coin-
fected with HHV-8. Although the role of IL-6 in the
pathogenesis of CD is unclear, the systemic symptoms
associated with CD have been linked to overproduction
of IL-6. In addition, viral IL-6 has known hematopoetic
and angiogenic effects[14] and treatment with anti-IL-6
antibodies have shown promising results[16].
Although the mediastinum is the most common loca-
tion for unicentric CD, it has been noted to occur in the
cervical, axillary and abdominal regions[2,13,14]. Sys-
temic symptoms are unusual in the hyaline-vascular CD
[14]. Mediastinal CD can cause esophageal varices
resulting from abnormally large amount of drainage into
esophageal veins. In addition, mediastinal masses have
been known to cause displacement and compression of
the esophagus resulting in dysphagia [17].
Multicentric CD can present as multifocal lymphade-
nopathy and hepatosplenomegaly is common[14]. In
plasma cell CD and multicentric CD constitutional
symptoms (fever, night sweats, fatigue and weight loss)
and laboratory abnormalities (anemia of chronic disease,
elevated erythrocyte sedimentation rate, thrombocytope-
nia, deranged liver function tests, hypoalbuminemia) can
occur[14].
Radiologic evaluation mainly involves computed
tomography (CT), magnetic resonance (MR) imaging
and positron emission tomography (PET/CT). The
typical feature on CT scan is a well circumscribed
mass with soft tissue attenuation and rarely calcifica-
tion. On MR imaging, these highly vascular tumors
appear solid and have intermediate to high signal com-
pared to muscle on T1 weighted images. Hyper intense
signal is seen on T2 weighted images. PET scan is a
useful modality for staging and monitoring response to
chemotherapy[18].
This case appears to represent an example of uni-
centric disease even though the spleen was enlarged,
particularly since the patient did not have the character-
istic constitutional symptomso fm u l t i c e n t r i cd i s e a s e .
Treatment options for unicentric CD include surgical
resection [1,2,13] and irradiation when surgery is not an
option[14]. Radiotherapy has been associated with acute
and late toxicities[19] as well as stenosis of the esopha-
gus, trachea and the bronchus when used for mediast-
inal CD tumors[20]. Preoperative embolization can be
attempted prior to surgical resection to minimize intrao-
perative bleeding from hypervascular mediastinal CD
tumors[21]. Multicentric CD requires systemic therapy
which can include chemotherapy, antiviral therapy, ster-
oids and the use of a humanized monoclonal antibody
to IL-6 receptor[14].
The differential diagnoses for posterior mediastinal
m a s s e sa r ee x t e n s i v ea n di n c l u d en e u r o g e n i ct u m o r s ,
sarcomas, lymphomas, pleural based tumors, broncho-
genic cysts, enteric cysts, teratomas, arteriovenous mal-
formations and metastatic masses[8]. These tumors,
although uncommon, should be included in the differen-
tial diagnoses and must be especially considered in the
presence of constitutional symptoms associated with
CD. Surgical resection of isolated posterior mediastinal
masses, as in this case, is usually indicated to exclude
malignancy and to prevent local mechanical effects.
Diagnostic modalities in addition to imaging, for pos-
terior mediastinal masses include ultrasound guided
endoscopic fine needle aspiration and percutaneous
transthoracic core biopsy. However, these can be techni-
cally difficult and specimens obtained by these techni-
ques may not yield sufficient material for an accurate
diagnosis. Excisional biopsy, particularly in unicentric
disease, is preferred in order to assess cell type and tis-
sue architecture, but can be associated with substantial
bleeding as these tumors are known to be highly vascu-
lar[8].
The technical aspects of this case underscore the char-
acteristic features of this tumor and its location. For
example, we elected to ligate the thoracic duct early and
intentionally because its integrity could not be assured
given its location and the extensive dissection required,
thereby decreasing the risk of a postoperative chy-
lothorax, a known complication of posterior mediastinal
surgery[22]. Knowledge of thoracic duct anatomy, vigi-
lance during dissection, prompt recognition of duct
injury can dramatically reduce the incidence of a post-
operative chylothorax. In addition, adherence of the
tumor to the esophagus demanded that we exclude eso-
phageal damage at completion of the resection. The
large number of lymphatic channels coursing through
the surface of the tumor requires ligation with multiple
clips since electrocautery should not be solely relied
upon to prevent lymphatic leakage.
Conclusion
We describe resection of a highly vascular posterior
mediastinal Castleman’s tumor with dense adhesions to
the esophagus employing a minimally-invasive approach.
Our case confirms that, using meticulous dissection and
hemostasis, VATS resection can be performed safely.
Particular attention to the thoracic duct with a view
towards early ligation is necessary to prevent postopera-
tive chylothorax. When the tumor is adherent to the
esophagus, an esophageal leak test should be performed
upon completion to assess the integrity of the esopha-
gus. Minimally invasive thoracoscopic resection is a safe
and feasible option in the management of posterior
mediastinal CD. Mediastinal CD, although uncommon
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terior mediastinal tumors.
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